術前消毒をヨードからクロルヘキシジンに


 術前消毒にクロルヘキシジンがヨードと比較してもSSIと表在菌の発生率が低く、コストも低減させられたという報告です。

Systematic Review and Cost Analysis Comparing Use of Chlorhexidine with Use of Iodine for Preoperative Skin Antisepsis to Prevent Surgical Site InfectionIn

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1219-29. Epub 2010 Oct 22.

・9つのRCTによる3,614人のメタ分析

・SSIの発症率は36%低下(RR0.64 [95% confidence interval, [0.51–0.80])

・患者一人当たり$16–$26の節約ができる

Objective.To compare use of chlorhexidine with use of iodine for preoperative skin antisepsis with respect to effectiveness in preventing surgical site infections (SSIs) and cost.

Methods.We searched the Agency for Healthcare Research and Quality website, the Cochrane Library, Medline, and EMBASE up to January 2010 for eligible studies. Included studies were systematic reviews, meta‐analyses, or randomized controlled trials (RCTs) comparing preoperative skin antisepsis with chlorhexidine and with iodine and assessing for the outcomes of SSI or positive skin culture result after application. One reviewer extracted data and assessed individual study quality, quality of evidence for each outcome, and publication bias. Meta‐analyses were performed using a fixed‐effects model. Using results from the meta‐analysis and cost data from the Hospital of the University of Pennsylvania, we developed a decision analytic cost‐benefit model to compare the economic value, from the hospital perspective, of antisepsis with iodine versus antisepsis with 2 preparations of chlorhexidine (ie, 4% chlorhexidine bottle and single‐use applicators of a 2% chlorhexidine gluconate [CHG] and 70% isopropyl alcohol [IPA] solution), and also performed sensitivity analyses.

Results.Nine RCTs with a total of 3,614 patients were included in the meta‐analysis. Meta‐analysis revealed that chlorhexidine antisepsis was associated with significantly fewer SSIs (adjusted risk ratio, 0.64 [95% confidence interval, [0.51–0.80]) and positive skin culture results (adjusted risk ratio, 0.44 [95% confidence interval, 0.35–0.56]) than was iodine antisepsis. In the cost‐benefit model baseline scenario, switching from iodine to chlorhexidine resulted in a net cost savings of $16–$26 per surgical case and $349,904–$568,594 per year for the Hospital of the University of Pennsylvania. Sensitivity analyses showed that net cost savings persisted under most circumstances.

Conclusions.Preoperative skin antisepsis with chlorhexidine is more effective than preoperative skin antisepsis with iodine for preventing SSI and results in cost savings.

これから)今日はちょうど感染委員会もあるので、この件を提案する。よって、朝は手術室をまわって現状を確認し、対応できる製品の確認をする。そして、JANISをはじめる予定のようなので、変更前後のSSIデータを整理し、評価する。

(Visited 24 times, 1 visits today)